Should I run BPC-157 and TB-500 together or pick one?

For a localised acute injury (tendinopathy, sprain, post-surgical) BPC-157 alone, dosed near the site, is usually sufficient. For systemic recovery from heavy training blocks or a chronic multi-site injury picture, the BPC-157 + TB-500 combination is additive: BPC-157 acts locally and on gut healing, TB-500 distributes systemically and supports cell migration to the injury.

Is BPC-157 active orally?

BPC-157 was originally isolated from gastric juice and is unusually stable in the digestive tract. Animal data show oral activity for gut-related conditions, but for tendon, ligament and post-surgical use the subcutaneous or intramuscular route remains the most-studied and most-cited.

How long until I feel a difference?

Athletes typically report a measurable change in pain or recovery within 2–3 weeks of starting BPC-157, and a more diffuse improvement in joint comfort within 3–4 weeks of starting TB-500. Tissue-level remodelling continues over the full 8–12 week protocol.

BPC-157 vs TB-500: which peptide for which injury?

Updated 2026-04-30 · Reviewed by the DeusPowershop editorial team

Two peptides dominate the soft-tissue recovery conversation: BPC-157 (Body Protection Compound, a 15-amino-acid fragment isolated from human gastric juice) and TB-500 (a 17-residue fragment of the larger thymosin β4 protein). They are often discussed interchangeably, but the underlying mechanisms — and the situations they are best suited to — are different.

Side-by-side

	BPC-157	TB-500
Origin	Gastric juice fragment	Thymosin β4 fragment
Primary action	Angiogenesis, fibroblast migration, NO & growth-hormone-receptor up-regulation	Actin sequestration, cell migration, anti-inflammatory cytokine modulation
Distribution	Local — best dosed near the injury	Systemic — diffuses widely after injection
Half-life	Short (~hours) — twice-daily dosing	Long (~days) — twice-weekly dosing
Best for	Tendon/ligament injury, post-surgical wounds, gut healing	Systemic recovery, chronic joint pain, multi-site injuries
Typical dose	250 µg subQ, 2× daily	2 mg subQ, 2× weekly (loading) → 2 mg weekly

When to choose BPC-157

Achilles, patellar or rotator-cuff tendinopathy.
Post-operative recovery (anchor sutures, meniscus repair).
Inflammatory bowel symptoms — there is animal data on gut-barrier repair.
Acute strains where you can dose subcutaneously near the lesion.

When to choose TB-500

Multi-site joint pain that is hard to localise.
Heavy contest-prep training blocks where systemic recovery is the bottleneck.
Chronic adductor / hip-flexor problems in combat-sport athletes.

The combination protocol

A 12-week stack is the most-discussed combination in coaching circles: BPC-157 250 µg subQ twice daily near the injury for the first 8 weeks, plus TB-500 2 mg twice weekly for weeks 1–4, then 2 mg weekly for weeks 5–12. See the beginner peptide stack guide for the same protocol presented week-by-week.

What the literature says — and doesn't

Both peptides have substantial pre-clinical (animal) data and a relatively thin human-trial base. BPC-157 is the better-studied of the two for musculoskeletal endpoints; TB-500 has more cardiovascular and dermal wound-healing data. Neither is on the WADA prohibited list as of the most recent update, but BPC-157 was added to the 2022 Monitoring Program — competitive athletes should check the current list before use.

Where to go next

Browse BPC-157, TB-500 and the rest of the peptide catalog.
If you are new to peptides, start with the beginner peptide stack.
Read the reconstitution guide before drawing your first dose.